Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
GlobeNewswire
Dose escalation in FHD-286 combination trial in AML continues to progress with clinical data expected in the second half of 2024;..
Dose escalation in FHD-286 combination trial in AML continues to progress with clinical data expected in the second half of 2024;..
Sarge opens the show by playing one of Dr. Peter Glidden's fantastic webinars on Bone and Joint Health! It compares and..
Eleven candidates stood after a recall petition led to the ousting of Peter Bone as an MP.